Explore 3 Stock Ideas & Industry Insights Download Free Report

SL Science Holding Limited Ordinary Shares

Company price
0.9598 USD 0.02 ( 2.32%)
Last update at 2026-11-09T15:43:00Z
VOLUME
6276
Market Cap
1071.05M

Momentum Score

…

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.90
Low
0.96
High
52 Week Price Range
1.85
Low
14.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.94
Dividend Yield
-
Revenue TTM
3.27M
Revenue Per Share
0.89
Gross Profit TTM
1.26M
Debt / Equity
0.09
ROE
-25.62%
Net Debt
-1.05M
ROCE
-163.39%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Income before tax -3.82M -1.13M 0.53M
Net income -3.82M -1.19M 0.40M
Selling general administrative 2.54M 1.11M 0.61M
Selling and marketing expenses - 0.00M 0.03M
Gross profit 0.78M 1.93M 0.74M
Reconciled depreciation 0.09M 0.05M 0.04M
Ebit -3.84M -1.20M 0.10M
Ebitda -3.74M -1.15M 0.13M
Depreciation and amortization 0.09M 0.05M 0.04M
Operating income -3.84M -1.20M 0.10M
Other operating expenses 6.03M 4.56M 0.78M
Tax provision -0.00M 0.06M 0.13M
Interest income 0.04M 0.05M 0.00M
Net interest income 0.04M 0.05M 0.00M
Income tax expense -0.00M 0.06M 0.13M
Total revenue 2.20M 3.36M 0.88M
Total operating expenses 4.61M 3.13M 0.64M
Cost of revenue 1.42M 1.43M 0.14M
Total other income expense net 0.02M 0.06M 0.44M
Net income from continuing ops -3.82M -1.19M 0.40M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Total assets 2.82M 5.93M 4.24M
Intangible assets - - 0.01M
Other current assets 0.04M 0.55M 1.62M
Total liab 0.53M 0.20M 0.67M
Total stockholder equity 2.28M 5.73M 3.57M
Other current liab 0.32M 0.06M 0.03M
Common stock 0.37M 0.37M 0.15M
Capital stock 0.37M 0.37M 0.15M
Retained earnings -5.48M -1.66M 0.00M
Cash 1.26M 3.68M 0.28M
Total current liabilities 0.47M 0.07M 0.18M
Net debt -1.05M -3.68M 0.27M
Short term debt 0.15M - 0.15M
Short long term debt total 0.21M - 0.55M
Other stockholder equity 6.93M 6.80M 3.42M
Total current assets 1.43M 5.86M 3.49M
Net receivables 0.13M 0.27M 0.12M
Inventory 0.00M 1.36M 1.48M
Accumulated other comprehensive income 0.47M 0.23M -
Non currrent assets other 0.93M 0.05M -
Non current assets total 1.39M 0.08M 0.75M
Capital lease obligations 0.21M 0.00M 0.55M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Total cashflows from investing activities -0.32M 0.12M -0.18M
Total cash from financing activities -0.88M 3.07M 2.86M
Net income -3.82M -1.19M 0.40M
Change in cash -2.88M 3.70M 0.22M
Begin period cash flow 4.14M 0.44M 0.22M
End period cash flow 1.26M 4.14M 0.44M
Total cash from operating activities -1.91M 0.28M -2.45M
Issuance of capital stock 0.00M 7.24M 0.00M
Depreciation 0.09M 0.05M 0.04M
Other cashflows from investing activities - 0.13M -
Change to inventory 1.35M 0.19M -1.49M
Change to account receivables 0.00M 0.03M -0.03M
Other cashflows from financing activities -0.88M -4.17M 2.86M
Capital expenditures 0.32M 0.01M 0.18M
Change in working capital 1.66M 1.27M -3.06M
Other non cash items 0.16M 0.16M 0.17M
Free cash flow -2.23M 0.27M -2.64M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
SLBT
SL Science Holding Limited Ordinary Shares
0.02
2.32%
0.96 - - 327.53 513.15 532.91
NVO
Novo Nordisk A/S
0.47
1.18%
40.78 41.58 31.15 2.13 32.99 2.11
VRTX
Vertex Pharmaceuticals Inc
0.34
0.06%
547.43 30.22 24.27 10.36 6.50 9.99
REGN
Regeneron Pharmaceuticals Inc
8.76
0.97%
913.11 29.07 20.12 7.57 3.82 6.95
ARGNF
argenx SE
-
-%
900.30 45.77 31.25 13.84 7.12 11.38

Profile*

SL Science Holding Limited Ordinary Shares

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

No. 479, Chongyang Rd., Taipei, Taiwan, 115010

886 2 2651 6826

14

Name Title Year Born
Mr. Ching-Dong Wang Founder, Chairman & CEO 1972
Mr. Ray Leung CFO & Director 1982
Dr. Ethan Shen Ph.D. CTO & Director 1977

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…